These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15056012)

  • 1. Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands.
    Shi ZD; Wei CQ; Lee K; Liu H; Zhang M; Araki T; Roberts LR; Worthy KM; Fisher RJ; Neel BG; Kelley JA; Yang D; Burke TR
    J Med Chem; 2004 Apr; 47(8):2166-9. PubMed ID: 15056012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides.
    Lee K; Zhang M; Liu H; Yang D; Burke TR
    J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain.
    Furet P; Gay B; Caravatti G; García-Echeverría C; Rahuel J; Schoepfer J; Fretz H
    J Med Chem; 1998 Aug; 41(18):3442-9. PubMed ID: 9719597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 4-(alpha-hydroxymalonyl)phenylalanine as a new phosphotyrosyl mimetic and its use in growth factor receptor bound 2 src-homology 2 (Grb2 SH2) domain-binding peptides.
    Kang SU; Worthy KM; Bindu LK; Zhang M; Yang D; Fisher RJ; Burke TR
    J Med Chem; 2005 Aug; 48(16):5369-72. PubMed ID: 16078854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic.
    Oishi S; Karki RG; Shi ZD; Worthy KM; Bindu L; Chertov O; Esposito D; Frank P; Gillette WK; Maderia M; Hartley J; Nicklaus MC; Barchi JJ; Fisher RJ; Burke TR
    Bioorg Med Chem; 2005 Apr; 13(7):2431-8. PubMed ID: 15755645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity.
    Shi ZD; Liu H; Zhang M; Worthy KM; Bindu L; Yang D; Fisher RJ; Burke TR
    Bioorg Med Chem; 2005 Jul; 13(13):4200-8. PubMed ID: 15893931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
    Song YL; Tan J; Luo XM; Long YQ
    Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. 2. 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic.
    Gao Y; Luo J; Yao ZJ; Guo R; Zou H; Kelley J; Voigt JH; Yang D; Burke TR
    J Med Chem; 2000 Mar; 43(5):911-20. PubMed ID: 10715157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding.
    Burke TR; Yao ZJ; Gao Y; Wu JX; Zhu X; Luo JH; Guo R; Yang D
    Bioorg Med Chem; 2001 Jun; 9(6):1439-45. PubMed ID: 11408162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
    Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
    J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.
    Liu WQ; Vidal M; Olszowy C; Million E; Lenoir C; Dhôtel H; Garbay C
    J Med Chem; 2004 Feb; 47(5):1223-33. PubMed ID: 14971902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic.
    Shi ZD; Karki RG; Oishi S; Worthy KM; Bindu LK; Dharmawardana PG; Nicklaus MC; Bottaro DP; Fisher RJ; Burke TR
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1385-8. PubMed ID: 15713392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic.
    Furet P; García-Echeverría C; Gay B; Schoepfer J; Zeller M; Rahuel J
    J Med Chem; 1999 Jul; 42(13):2358-63. PubMed ID: 10395476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for Tyr in the consensus sequence Y-E-N of a novel nonphosphorylated inhibitor to the Grb2-SH2 domain.
    Long YQ; Yao ZJ; Voigt JH; Lung FD; Luo JH; Burke TR; King CR; Yang D; Roller PP
    Biochem Biophys Res Commun; 1999 Nov; 264(3):902-8. PubMed ID: 10544028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.